98%
921
2 minutes
20
Background: Heart failure is a complex syndrome that requires long-term management, including self-care, to prevent decompensation and hospitalization. Although a range of interventions exists, evidence supporting their effectiveness remains limited, prompting calls for more theory-informed and user-centered approaches. The rapid advancement of mobile and digital technologies offers new opportunities to improve self-care, particularly when interventions are grounded in behavioral theory and shaped by user input.
Objective: This study aimed to define user-centered, theory-informed requirements for a digital intervention to support self-care among people with heart failure. We combined the Behavior Change Wheel (BCW) with user-centered design (UCD) to explore self-care barriers and generate actionable intervention requirements.
Methods: A qualitative study was conducted, involving 4 workshops with people with heart failure (n=16) and informal caregivers (n=4) across metropolitan and regional Australia. Guided by UCD principles, the workshops explored self-care barriers and elicited ideas for a digital intervention. Barriers were coded using the capability, opportunity, motivation, and behavior (COM-B) model and the Theoretical Domains Framework to identify behavioral determinants and user needs. Ideas and preferences for the intervention were analyzed using requirements analysis and affinity mapping to generate themes describing intervention components ("what" the system should do) and user requirements ("how" it should operate). Intervention components were then mapped to relevant BCW intervention functions.
Results: Participants identified self-care barriers across all 3 COM-B components and 11 of 14 Theoretical Domains Framework domains, including barriers related to capability (eg, lack of knowledge and forgetfulness), opportunity (eg, busy lifestyle and limited access to resources), and motivation (eg, emotional burden and lack of confidence). These were translated into 28 distinct user needs. From participants' ideas, 6 themes relating to intervention components were identified: education, monitoring and feedback, social connection and support, psychological and emotional support, planning and preparing, and health care support. These components mapped to 7 BCW functions: education, persuasion, incentivization, training, environmental restructuring, modeling, and enablement. Additionally, 6 user requirement themes were developed: physical design, accessibility and usability, personalization and control, engagement and user experience, support and implementation, and integration and system organization.
Conclusions: This study demonstrates the value of integrating UCD with the BCW to develop intervention requirements that are both user-centered and theoretically grounded. By exploring both what the intervention should do and how it should do it, we identified actionable requirements that bridge the gap between understanding behavior and developing effective solutions. Future work can focus on translating these requirements into prototype interventions and evaluating their feasibility, acceptability, and effectiveness.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12377876 | PMC |
http://dx.doi.org/10.2196/72589 | DOI Listing |
JAMA Cardiol
September 2025
Seymour, Paul and Gloria Milstein Division of Cardiology, Department of Medicine, Columbia University Irving Medical Center and New York-Presbyterian Hospital, New York, New York.
Importance: Transthyretin cardiac amyloidosis (ATTR-CA) is an underdiagnosed but treatable cause of heart failure (HF) in older individuals that occurs in the context of normal wild-type (ATTRwt-CA) or an abnormal inherited (ATTRv-CA) TTR gene variant. While the most common inherited TTR variant, V142I, occurs in 3% to 4% of self-identified Black Americans and is associated with excess morbidity and mortality, the prevalence of ATTR-CA in this at-risk population is unknown.
Objective: To define the prevalence of ATTR-CA and proportions attributable to ATTRwt-CA or ATTRv-CA among older Black and Caribbean Hispanic individuals with HF.
Hormones (Athens)
September 2025
Division of Endocrinology, Baltimore VA Medical Center, Baltimore, MD, USA.
Sodium-glucose co-transporter 2 inhibitors (SGLT2i) are a fairly new class of agents for diabetes that have demonstrated significant benefits in glycemic control and cardiovascular outcomes with outpatient use. The aim of this review is to provide an overview of the effect of SGLT2i use on glycemic control and clinical outcomes in the hospital setting.An electronic search of PubMed was conducted to analyze publications that assessed the inpatient use of SGLT2i and included patients with diabetes.
View Article and Find Full Text PDFCurr Atheroscler Rep
September 2025
Division of Gastroenterology and Hepatology, Lynda K. and David M. Underwood Center for Digestive Health, Houston Methodist Hospital, Houston, TX, USA.
Purpose Of Review: This review aims to characterize the known cardiovascular (CV) manifestations associated with inflammatory bowel disease (IBD) and the underlying mechanisms driving these associations.
Recent Findings: Gut dysbiosis, a hallmark of patients with IBD, can result in both local and systemic inflammation, thereby potentially increasing the risk of cardiovascular disease (CVD) in the IBD population. Micronutrient deficiencies, anemia, and sarcopenia independently increase the risk of CVD and are frequent comorbidities of patients with IBD.
Clin Res Cardiol
September 2025
Department of Cardiology, University Heart Center, University Hospital Zurich, Center for Translational and Experimental Cardiology (CTEC), University of Zurich, Rämistrasse 100, 8091, Zurich, Switzerland.
Background: Diabetic patients with ST-segment elevation myocardial infarction (STEMI) are at an increased risk of cardiovascular events as compared to non-diabetic patients. This analysis investigated outcomes of diabetic patients presenting with multivessel disease (MVD) and STEMI in a contemporary trial and the relevance of an immediate versus staged multivessel PCI strategy in this high-risk population.
Methods: Patients enrolled in the MULTISTARS AMI trial were stratified according to the presence/absence of diabetes.
JACC Basic Transl Sci
September 2025
BHF Centre for Cardiovascular Science, Queens Medical Research Institute, University of Edinburgh, Edinburgh, United Kingdom; Department of Pathology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre, Maastricht, the Netherlands. Electronic address: andy.bak
Coronary artery bypass graft (CABG) surgery remains the gold standard of care to prevent myocardial ischemia in patients with advanced atherosclerosis; however, poor long-term graft patency remains a considerable and long-standing problem. Excessive vascular smooth muscle cell (SMC) proliferation in the grafted tissue is recognized as central to late CABG failure. We previously identified SMILR, a human-specific SMC-enriched long noncoding RNA that drives SMC proliferation, suggesting that targeting SMILR expression could be a novel way to prevent neointima formation, and thus CABG failure.
View Article and Find Full Text PDF